четверг, 30 мая 2013 г.

New Innovative Combined Oral Contraceptive Launched In The UK

Zoely ® (nomegestrol acetate/17beta-estradiol) - new combined oral contraceptive that contains an innovative combination of hormones launches in the UK MSD (known as Merck in the United States and Canada) (NYSE:MRK) today announced that Zoely (nomegestrol acetate 2.5 mg/17beta-estradiol 1.5 mg) is now available in the UK for the prevention of pregnancy...



Комментариев нет:

Отправить комментарий